KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Elevance Health (ELV) EBT Margin (2016 - 2025)

Elevance Health (ELV) has disclosed EBT Margin for 17 consecutive years, with 6.71% as the latest value for Q2 2025.

  • On a quarterly basis, EBT Margin rose 105971.0% to 6.71% in Q2 2025 year-over-year; TTM through Sep 2025 was 1.1%, a 779.0% decrease, with the full-year FY2024 number at 4.47%, down 4.0% from a year prior.
  • EBT Margin was 6.71% for Q2 2025 at Elevance Health, down from 0.5% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 8.25% in Q2 2021 to a low of 1066.43% in Q2 2024.
  • A 5-year average of 71.76% and a median of 3.47% in 2023 define the central range for EBT Margin.
  • Peak YoY movement for EBT Margin: tumbled -107310bps in 2024, then soared 105971bps in 2025.
  • Elevance Health's EBT Margin stood at 103.77% in 2021, then skyrocketed by 103bps to 2.68% in 2022, then decreased by -14bps to 2.3% in 2023, then crashed by -7861bps to 178.24% in 2024, then soared by 96bps to 6.71% in 2025.
  • Per Business Quant, the three most recent readings for ELV's EBT Margin are 6.71% (Q2 2025), 0.5% (Q1 2025), and 178.24% (Q4 2024).